Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2021 3
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Reactogenicity to the mRNA-1273 Booster According to Previous mRNA COVID-19 Vaccination.
Parés-Badell O, Zules-Oña R, Armadans L, Pinós L, Borrás-Bermejo B, Otero S, Rodrigo-Pendás JÁ, Vivet-Escalé M, Cossio-Gil Y, Agustí A, Aguilera C, Campins M, Martínez-Gómez X. Parés-Badell O, et al. Among authors: pinos l. Vaccines (Basel). 2022 Jul 29;10(8):1217. doi: 10.3390/vaccines10081217. Vaccines (Basel). 2022. PMID: 36016105 Free PMC article.
Vaccine hesitancy among paediatric nurses: Prevalence and associated factors.
Elizondo-Alzola U, G Carrasco M, Pinós L, Picchio CA, Rius C, Diez E. Elizondo-Alzola U, et al. Among authors: pinos l. PLoS One. 2021 May 19;16(5):e0251735. doi: 10.1371/journal.pone.0251735. eCollection 2021. PLoS One. 2021. PMID: 34010321 Free PMC article. Clinical Trial.
Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial.
Borobia AM, Carcas AJ, Pérez-Olmeda M, Castaño L, Bertran MJ, García-Pérez J, Campins M, Portolés A, González-Pérez M, García Morales MT, Arana-Arri E, Aldea M, Díez-Fuertes F, Fuentes I, Ascaso A, Lora D, Imaz-Ayo N, Barón-Mira LE, Agustí A, Pérez-Ingidua C, Gómez de la Cámara A, Arribas JR, Ochando J, Alcamí J, Belda-Iniesta C, Frías J; CombiVacS Study Group. Borobia AM, et al. Lancet. 2021 Jul 10;398(10295):121-130. doi: 10.1016/S0140-6736(21)01420-3. Epub 2021 Jun 25. Lancet. 2021. PMID: 34181880 Free PMC article. Clinical Trial.
Effectiveness of varicella vaccines as postexposure prophylaxis.
Brotons M, Campins M, Méndez L, Juste C, Rodrigo JA, Martínez X, Hermosilla E, Pinós L, Vaqué J. Brotons M, et al. Among authors: pinos l. Pediatr Infect Dis J. 2010 Jan;29(1):10-3. doi: 10.1097/INF.0b013e3181b36022. Pediatr Infect Dis J. 2010. PMID: 19841607
Local and Systemic Adverse Reactions to mRNA COVID-19 Vaccines Comparing Two Vaccine Types and Occurrence of Previous COVID-19 Infection.
Parés-Badell O, Martínez-Gómez X, Pinós L, Borras-Bermejo B, Uriona S, Otero-Romero S, Rodrigo-Pendás JÁ, Cossio-Gil Y, Agustí A, Aguilera C, Campins M. Parés-Badell O, et al. Among authors: pinos l. Vaccines (Basel). 2021 Dec 10;9(12):1463. doi: 10.3390/vaccines9121463. Vaccines (Basel). 2021. PMID: 34960209 Free PMC article.